Identifikasi Drug Related Problems pada Pasien Kanker Paru di RSUD Dr. Pirngadi Medan

Abstract

Background: Lung cancer is the most common cause of death from cancer worldwide. The vast majority of lung cancer are attributable to cigarette smoking. To improve the quality of life of patients with lung cancer, polypharmacy is required. Polypharmacy was most often associated with the occurence of DRPs. Objective: This research aimed to identify the incidence, number and percentage of DRPs in management of patients with lung cancer at RSUD Dr. Pirngadi Medan. Method: This research uses a descriptive method which collects, analyzes and interprets data. Data collection was carried out retrospectively with the aim of identifying the incidence of DRPs in lung cancer patients at RSUD Dr. Pirngadi Medan period January - December 2023. The incidence of DRPs were analyzed based on the Cipolle classification and reliable references. Results: The results showed, there were male 49 (79%) and female 13 (21%), with mean age 56,5 ± 0,462 years. There were 44 patients (70.96%) experienced DRPs with an average of DRPs were 1 cases per patient. The overall incidence of DRPs was 143 cases, the most common DRPs occurred were adverse drug reactions 118 cases (82,51%), followed by needs additional drug theraphy 9 cases (6,29%), ineffective drug 9 cases (6,29%), drug without indication 6 case (4.16%), and low dose 1 case (0.69%). Conclusion: Incidence of DRPs in management of lung cancer is still high. Health care practitioner should seek to minimize incidence of DRPs to improve the therapeutic outcomes.